Insider buying last 90 days
No open-market insider purchases were filed for HLN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every HLN insider filing, plotted on the chart in Gekko.Open HLN in Gekko
Gekko Brief
AI summaryNov 4 closeHaleon's week was dominated by disappointing third-quarter results, with organic sales growth of 2.6% falling short of expectations as volume/mix contributed only 0.5%. The guidance cut that followed prompted downgrades from both Berenberg and Jefferies, each moving Haleon to 'hold' and citing execution risk, inconsistent revenue delivery, and the need for lower prices and increased marketing spend outside oral health. Several price target revisions followed, with the average 12-month target most recently cut to $10.38, implying 18% upside from the prior close. Separately, Haleon signed two virtual power purchase agreements with Lightsource bp in Spain to source renewable electricity for its operations.
Shares closed at $9.23, up 4.4% on the day but still below both the 50-day average of $9.47 and the 200-day average of $9.75, with the 50-day beneath the 200-day. The GekkoIndex reads 63.4, placing Haleon in the Accumulation zone. Price sits 30.3% below Gekko Fair Value of $13.25.
The next earnings date falls on 4 March 2027, 119 days out and beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in their respective windows. Seasonality over the next 20 trading days has averaged a 5.2% gain across 4 years, higher in 3 of them. A Director/PDMR filing showed a small share purchase by an independent non-executive director on 30 October. The gap to Gekko Fair Value and the cluster of recent analyst downgrades following the guidance cut are worth noting.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Haleon price vs fair value
Close $9.23200-day averageGekko Fair Value $13.25
Haleon quick facts
- Market cap
- $40.59B
- P/E ratio
- 18.1
- Forward P/E
- 14.5
- EPS, TTM
- $0.49
- Revenue, TTM
- $11.15B
- Profit margin
- 14.5%
- Dividend yield
- 2.26%
- Beta
- 0.29
- Volume
- 28.02M avg 21.67M
- 1-year return
- −1.6%
- Typical daily move
- ±3.3%
- Typical 20-day move
- ±4.1%
- 50-day average
- $9.47
- 200-day average
- $9.75
- Next earnings
- Mar 4 before open
- Shares outstanding
- 4.40B
Haleon swing-trade checklist
Haleon scores 4 supportive, 0 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive0 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $9.23 is below the 50-day ($9.47) and 200-day ($9.75) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
63.4, Accumulation
Reading 63.4 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
30.3% below
Price is 30.3% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 119 days
Next report Mar 4, 2027, 119 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+5.2% on average
From this point in the calendar, the next 20 trading days averaged +5.2% over 4 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Haleon stock chart and price history
Haleon closed at $9.23 on Nov 4, 2026, −1.6% over the past year, inside a 52-week range of $8.38 to $11.28.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +4.1%
- 3 months
- −8.0%
- 6 months
- 0.0%
- 1 year
- −1.6%
The full HLN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HLN in Gekko
Follow Haleon through every session
Put HLN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track HLN in GekkoFree for 7 days. No credit card required.
About Haleon
Haleon develops, manufactures, and distributes consumer wellness products, covering everything from early research through to getting finished goods onto shelves around the world. Its offerings span oral care, pain relief, respiratory support, and digestive health, along with vitamins, minerals, and other supplements. Among its recognizable names are Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum.
The business operates on an integrated model, running the full chain from scientific development to production and distribution rather than outsourcing these stages separately. Its goods reach consumers across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region, giving it a broad geographic footprint in the markets it serves.
Haleon traces its origins to 2021, when it was formed under the name DRVW 2022 plc before adopting its current name, Haleon plc, in February 2022. The company is headquartered in Brentford, in the United Kingdom, and its shares trade under the ticker HLN.
- Sector
- Health technology
- Website
- haleon.com
Haleon GekkoIndex: the smart money zone
Haleon’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 63.4, in the Accumulation zone, up 11.9 points over five sessions.
63.4Accumulation
Up 11.9 points over five sessions, from the Neutral zone.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 34 | +1.0% | +2.5% | ||
| Accumulation (current zone) | 204 | −0.1% | +0.5% | ||
| Neutral | 368 | +0.2% | +0.8% | ||
| Distribution | 44 | +0.3% | −1.0% | ||
| Selling | 0 | Not available | |||
Average HLN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the HLN price, zone by zone.Track HLN in Gekko
Is Haleon stock overvalued? Gekko Fair Value
Haleon trades 30.3% below Gekko Fair Value of $13.25, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Haleon shares are worth, recalculated every trading day.
$13.25
Gekko Fair Value, Nov 4, 2026
30.3% Undervalued
At the end of Aug 2026 the price was 29.6% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open HLN in Gekko
Haleon insider and Congress trading
No open-market insider purchases were filed for Haleon, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in HLN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for HLN, plotted on the chart in Gekko.Open HLN in Gekko
Haleon earnings: next date and track record
Haleon reports on Mar 4, 2027, before the open (119 days away), and beat the EPS estimate in 4 of its last 8 reports.
Next earnings report
Mar 4, 2027
Expected before the open, 119 days away
- EPS estimate
- $0.28
- Revenue estimate
- $7.58B
4 of 8reports beat the EPS estimate
±1.7%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Haleon reported 3.1% organic sales growth in Q2, improving sequentially from 2.2% in Q1, with volume/mix contribution of 1.4%. Emerging markets grew 6.3% despite headwinds in Middle East markets. North America showed 3.1% growth with 2% volume, driven by shelf resets, innovation launches including Centrum Age Defy and clinical repair products, and double-digit e-commerce growth. A&P spending grew 3.2%, representing approximately 21% of sales.
- Guidance
- Management reaffirmed full-year organic sales growth guidance of 3%-5%, expecting H2 to be stronger than H1. Planned step-up in A&P investment in H2, including increased spend in China Douyin channel and U.S. market activations.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.28 est $0.27 | $7.52B est $6.40B | −4.0% |
| Apr 29, 2026 | $0.00 est $0.12 | — | −2.4% |
| Feb 25, 2026 | $0.26 est $0.25 | $7.51B est $7.57B | −2.9% |
| Oct 30, 2025 | $0.14 est $0.24 | $7.52B est $2.76B | +2.4% |
| Jul 31, 2025 | $0.24 est $0.24 | $7.25B est $7.48B | +0.2% |
| Apr 30, 2025 | $0.13 est $0.00 | — | +0.5% |
| Feb 27, 2025 | $0.05 est $25.25 | $7.14B est $2.74B | −0.2% |
| Oct 31, 2024 | $0.14 est $0.11 | $6.93B est $11.04B | −0.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Haleon stock forecast and analyst price targets
Analysts’ average 12-month price target for Haleon is $10.80, +17.0% from the last close, from 1 firm rating the stock in the last 90 days.
$10.80consensus 12-month target, +17.0% from the last close
Each firm’s latest rating in the last 90 days: 1 firm.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 6 | Morgan Stanley | $6.20 | −32.8% |
+0.5%average 20-day move after past Accumulation readings
+5.2%average move over the next 20 trading days in the last 4 years
±3.3%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Haleon seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Haleon averaged +5.2% across the last 4 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.8% | 3 of 4 |
| Next 10 trading days | +2.7% | 3 of 4 |
| Next 15 trading days | +5.2% | 3 of 4 |
| Next 20 trading days | +5.2% | 3 of 4 |
| Next 30 trading days | +7.4% | 4 of 4 |
For scale, HLN’s typical 20-trading-day move in either direction is about 4.1%.
Haleon market cap and key statistics
Haleon’s market cap is $40.59B, with a P/E ratio of 18.1 and revenue of $11.15B over the last twelve months.
Valuation
- Market cap
- $40.59B
- P/E ratio
- 18.1
- Forward P/E
- 14.5
- EPS, TTM
- $0.49
- Gekko Fair Value
- $13.25
Trading
- Volume
- 28.02M
- Avg volume, 20 days
- 21.67M
- 52-week high
- $11.28
- 52-week low
- $8.38
- Shares outstanding
- 4.40B
Financials
- Revenue, TTM
- $11.15B
- Profit margin
- 14.5%
- Return on equity
- 10.1%
- Quarterly earnings growth, YoY
- −4.5%
Risk and income
- Beta
- 0.29
- Typical daily move
- ±3.3%
- Typical 20-day move
- ±4.1%
- Dividend yield
- 2.26%
Haleon stock news this week
Coverage of Haleon this week reads positive: 6 positive, 3 neutral and 5 negative headlines.
- Lightsource bp signs two solar VPPAs with Haleon in SpainRenewables Now, Nov 4
- Haleon margin reset and weak sales beyond oral care prompt Jefferies downgrade to 'hold'Proactive financial news, Nov 4
- Haleon plc Stock 12‑Month Price Target Cut to $10.38, Implies 18% UpsideTradingView, Nov 3
- Berenberg downgrades Haleon to 'hold', cites higher execution riskSharecast.com, Nov 2
- REG - Haleon PLC - Director/PDMR ShareholdingTradingView, Nov 2
- Haleon plc Stock 12‑Month Price Target Cut to $10.73, Implies 25% UpsideTradingView, Oct 31
Haleon stock FAQ
What is Haleon’s market cap?
Haleon’s market cap is $40.59B at the Nov 4, 2026 close of $9.23, with 4.40B shares outstanding. The shares trade on a P/E ratio of 18.1.
What is the Haleon stock forecast?
The consensus analyst 12-month price target for Haleon is $10.80, +17.0% from the last close. Of the 1 firm that rated the stock in the last 90 days, 1 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Haleon stock overvalued or undervalued?
On Gekko’s estimate Haleon is undervalued: the Nov 4, 2026 close of $9.23 is 30.3% below Gekko Fair Value of $13.25. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Haleon report earnings next?
Haleon is expected to report on Mar 4, 2027, before the market opens (119 days away). Analysts expect earnings of $0.28 per share on revenue of $7.58B. Haleon beat the earnings estimate in 4 of its last 8 reports, moving 1.7% on average across the report.
What is Haleon’s 52-week high and low?
Haleon’s 52-week high is $11.28 and its 52-week low is $8.38; it closed at $9.23 on Nov 4, 2026, −1.6% over the past year. Over the last five years the shares peaked at $11.42 on Jun 2, 2025.
Is Haleon stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Haleon the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.